> top > docs > PMC:7243778 > spans > 23961-25859 > annotations

PMC:7243778 / 23961-25859 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
602 0-10 Species denotes SARS-CoV-2 Tax:2697049
603 37-45 Species denotes patients Tax:9606
604 219-227 Species denotes patients Tax:9606
605 440-448 Species denotes patients Tax:9606
606 473-481 Species denotes patients Tax:9606
607 488-495 Species denotes Patient Tax:9606
608 541-551 Species denotes SARS-CoV-2 Tax:2697049
609 583-590 Species denotes persons Tax:9606
610 592-600 Species denotes Patients Tax:9606
611 863-871 Species denotes patients Tax:9606
612 967-972 Species denotes Ebola Tax:1570291
613 976-984 Species denotes SARS-CoV Tax:694009
614 1029-1034 Species denotes human Tax:9606
615 1376-1384 Species denotes patients Tax:9606
616 1390-1400 Species denotes SARS-CoV-2 Tax:2697049
617 1445-1453 Species denotes patients Tax:9606
618 1461-1469 Species denotes patients Tax:9606
619 1547-1555 Species denotes patients Tax:9606
620 956-965 Species denotes influenza Tax:11308
621 842-850 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T102 112-115 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T103 321-324 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T104 411-414 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T105 415-423 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T106 651-659 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T107 764-772 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T108 790-796 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T109 1275-1281 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970
T110 1343-1351 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T111 1595-1601 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T93 0-8 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T94 541-549 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T95 842-850 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T96 956-965 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T97 967-972 Disease denotes Ebola http://purl.obolibrary.org/obo/MONDO_0005737
T98 976-984 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T99 1089-1099 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T100 1390-1398 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T303 433-439 http://purl.obolibrary.org/obo/UBERON_0003100 denotes female
T304 468-472 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T305 468-472 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T306 606-607 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T307 642-643 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T308 704-705 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T309 790-796 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T310 872-875 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T311 881-887 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T312 905-911 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T313 940-947 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T314 1029-1034 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T315 1275-1281 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T316 1441-1444 http://purl.obolibrary.org/obo/CLO_0050884 denotes ten
T317 1475-1480 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T318 1595-1601 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T319 1607-1608 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T320 1880-1881 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T142 468-472 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T185 0-213 Sentence denotes SARS-CoV-2 nAbs could be detected in patients from 10 to 15 days after symptoms onset and the positive rate for IgG reached close to 100% around 20 days [81,82] with the highest level during day 31–40 since onset.
T186 214-307 Sentence denotes Some patients (5.7%) had neutralizing Abs titers under the detectable level (ID50: <40) [83].
T187 308-398 Sentence denotes The level of IgG antibodies was different between gender, age and clinical classification.
T188 399-487 Sentence denotes The average IgG antibody level in female patients was higher than in male patients [84].
T189 488-591 Sentence denotes Patient over 40 years old developed higher levels of SARS-CoV-2 specific nAbs than the younger persons.
T190 592-671 Sentence denotes Patients with a worse clinical classification had a higher antibody titer [83].
T191 672-751 Sentence denotes This remark is useful to select a research candidate and to save research time.
T192 752-888 Sentence denotes The passive antibody therapy, such as plasma fusion containing polyclonal antibodies from COVID-19 neutralized patients has been tested.
T193 889-1016 Sentence denotes This method was tested as an option to treat other viruses such as influenza, Ebola or SARS-CoV [[85], [86], [87], [88], [89]].
T194 1017-1127 Sentence denotes The lack of human sera, and the possibility of contamination with other infectious agents limit this strategy.
T195 1128-1233 Sentence denotes However, several groups have reported some positive results demonstrating the potential of this approach.
T196 1234-1434 Sentence denotes After one dose of 200 mL of convalescent plasma derived from recently recovered donors with the neutralizing antibody titers above 1:640, the patients with SARS-CoV-2 positive revealed an improvement.
T197 1435-1512 Sentence denotes Among ten patients, seven patients were virus-negative post transfusion [90].
T198 1513-1692 Sentence denotes Whereas in another study, among 5 patients received transfusion with convalescent plasma with a neutralization titer >40, 3 have been discharged from the hospital (length of stay:
T199 1693-1779 Sentence denotes 53, 51, and 55 days), and 2 are in stable condition at 37 days after transfusion [91].
T200 1780-1898 Sentence denotes More studies might brighter this approach but evaluation in clinical trials are also still far from a bold conclusion.

2_test

Id Subject Object Predicate Lexical cue
32450171-12777656-66454505 987-989 12777656 denotes 85
32450171-17914053-66454506 993-995 17914053 denotes 86
32450171-26735992-66454507 999-1001 26735992 denotes 87
32450171-15214887-66454508 1005-1007 15214887 denotes 88
32450171-15616839-66454509 1011-1013 15616839 denotes 89
32450171-32253318-66454510 1508-1510 32253318 denotes 90